Uncategorized


October 1, 2026

Rx Pricing: Part B MFN Rule & Part D Implications

By John Leppard

While CMS’s finalized GLOBE most favored nation (MFN) rule for Medicare Part B meaningfully narrows its reach / implications, we view its methodology for excluding manufacturers participating in the GENEROUS MFN Medicaid model as legally…

Read More >>

September 30, 2026

[Municipal Hospitals, HCA, THC, OPCH, CVS, MRK, PFE]: 340B Drug Reimbursement Expectations in the Final Medicare OPPS Rule

By Beth Steindecker

With CMS likely to release its final CY27 Medicare Hospital Outpatient Prospective Payment System (OPPS) rule in early November, we continue to expect a substantial cut to Medicare payment for 340B-acquired drugs administered in participating…

Read More >>

September 29, 2026

(MSFT, AMZN, GOOGL, META, ORCL, CRWV, DLR, EQIX, NVDA, AMD, VRT) Data Center Opposition Will Not Likely End with the Midterms

By Joe Lieber

With data center moratoriums recently gaining steam across the country, we do not expect political opposition to data centers to fade after the midterms. Governors facing elections in 2027 and 2028 may face growing pressure…

Read More >>

September 28, 2026

Capitol Policy Weekly: Data Center Costs, Stock Trading, Permitting and Chinese Vehicle Imports

By Joe Lieber

This week is the Senate’s last scheduled week before the elections. Senators plan to pass the Protect College Sports Act on Monday, an odd legislative choice, in our view, when voters are focused on inflation…

Read More >>

September 24, 2026

Senate Election Update: Democrats in the Driver’s Seat

By Joe Lieber

We have moved our odds to a 60% chance of Democrats retaking the Senate from our previous assessment of 50/50. We continue to believe there is an 85% chance the House flips control to the…

Read More >>

September 24, 2026

Grail (GRAL): Narrowed Label & Coverage Questions

By John Leppard

The FDA appears likely to approve Grail’s (GRAL) Galleri by ~1Q27 following yesterday’s advisory committee vote, though we suspect a narrowed label, removal of the word “early” from its indication for the “detection of multiple…

Read More >>

September 22, 2026

[OSCR, CNC, HCA, THC, DVA, FRE.DE]: ACA Anti-Fraud Actions are More Noise Than New – and Potentially Material

By Beth Steindecker

This afternoon’s White House announcement of additional Obamacare anti-fraud actions does not change the direction of the ACA reset underway over the past year, nor our expectations for 2027 and 2028. While the actions appear…

Read More >>

September 22, 2026

(OpenAI, Anthropic, GOOG, META, SPCX, NVDA, AMD) AI Regulation Update

By Joe Lieber

President Trump’s comments today at the UN—and despite the calls for regulation from the large AI frontier models CEOs—reinforces our view that this administration intends to maintain a light-touch approach to AI regulation absent a…

Read More >>

September 22, 2026

Labs & Dx: Draft CY27 Rate Winners & Losers

By John Leppard

CMS’s preliminary CY27 rates for lab codes targeted through the next phase of adjustments under the Protecting Access to Medicare Act (PAMA), released last night, appear largely consistent with the ~$100 M risk projections previously…

Read More >>

September 21, 2026

Capitol Policy Weekly: Trump-Xi Summit, Trump’s UN Appearance, Iran and Permitting Reform in Focus

By Joe Lieber

The week ahead will be busy despite the fact that the House has left Washington until after the midterm elections. The Senate is scheduled to remain in session through Oct. 2 but could complete its…

Read More >>